Optimer Pharmaceuticals, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has made significant strides in developing innovative therapies, particularly in the fields of gastrointestinal and infectious diseases. With a focus on advancing patient care, Optimer is renowned for its flagship product, Dificid (fidaxomicin), which offers a unique treatment option for Clostridium difficile infections. Operating primarily in North America and expanding its reach globally, Optimer Pharmaceuticals has established a strong market position through its commitment to research and development. The company’s dedication to addressing unmet medical needs has garnered recognition within the industry, solidifying its reputation as a leader in specialised pharmaceuticals.
We don't have data for Optimer Pharmaceuticals, Inc., but we can show you information about their parent organization instead.
View parent company